263 related articles for article (PubMed ID: 9374268)
21. GABAA-5-HT1A receptor interaction in the mediobasal hypothalamus.
Guptarak J; Selvamani A; Uphouse L
Brain Res; 2004 Nov; 1027(1-2):144-50. PubMed ID: 15494165
[TBL] [Abstract][Full Text] [Related]
22. Reduced efficacy of 8-OH-DPAT's inhibition of lordosis behavior by prior estrogen treatment.
Trevino A; Wolf A; Jackson A; Price T; Uphouse L
Horm Behav; 1999 Jun; 35(3):215-23. PubMed ID: 10373334
[TBL] [Abstract][Full Text] [Related]
23. The PKC inhibitor, bisindolymaleimide, blocks DOI's attenuation of the effects of 8-OH-DPAT on female rat lordosis behavior.
Selvamani A; Lincoln C; Uphouse L
Behav Brain Res; 2007 Apr; 179(1):99-106. PubMed ID: 17336403
[TBL] [Abstract][Full Text] [Related]
24. Progesterone reduces the inhibitory effect of a serotonin 1B receptor agonist on lordosis behavior.
Uphouse L; Guptarak J; Hiegel C
Pharmacol Biochem Behav; 2010 Dec; 97(2):317-24. PubMed ID: 20816890
[TBL] [Abstract][Full Text] [Related]
25. Effects of the 5-HT1A agonist, 8-OH-DPAT, on sexual behaviors of the proestrous rat.
Uphouse L; Montanez S; Richards-Hill R; Caldarola-Pastuszka M; Droge M
Pharmacol Biochem Behav; 1991 Jul; 39(3):635-40. PubMed ID: 1838412
[TBL] [Abstract][Full Text] [Related]
26. Prior treatment with estrogen attenuates the effects of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
Jackson A; Uphouse L
Horm Behav; 1996 Jun; 30(2):145-52. PubMed ID: 8797023
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of the 5-HT1A agonists, 5-hydroxy- and 5-methoxy-(3-di-n-propylamino)chroman, on female lordosis behavior.
Uphouse L; Caldarola-Pastuszka M; Moore N
Neuropharmacology; 1993 Jul; 32(7):641-51. PubMed ID: 8361579
[TBL] [Abstract][Full Text] [Related]
28. Noradrenergic innervation to the VMN or MPN is not necessary for lordosis.
Davis BL; Manzanares J; Lookingland KJ; Moore KE; Clemens LG
Pharmacol Biochem Behav; 1991 Jul; 39(3):737-42. PubMed ID: 1784602
[TBL] [Abstract][Full Text] [Related]
29. Differential influence of two serotonin 5-HT3 receptor antagonists on spinal serotonin-induced analgesia in rats.
Bardin L; Jourdan D; Alloui A; Lavarenne J; Eschalier A
Brain Res; 1997 Aug; 765(2):267-72. PubMed ID: 9313899
[TBL] [Abstract][Full Text] [Related]
30. Dilute estradiol implants and progestin receptor induction in the ventromedial nucleus of the hypothalamus: correlation with receptive behavior in female rats.
Pleim ET; Brown TJ; MacLusky NJ; Etgen AM; Barfield RJ
Endocrinology; 1989 Apr; 124(4):1807-12. PubMed ID: 2924724
[TBL] [Abstract][Full Text] [Related]
31. Female sexual behavior following intracerebral infusion of the 5-HT1A agonist, 8-OH-DPAT, into the medial preoptic area.
Uphouse L; Caldarola-Pastuszka M
Brain Res; 1993 Jan; 601(1-2):203-8. PubMed ID: 8431766
[TBL] [Abstract][Full Text] [Related]
32. Intrahypothalamic implants of noradrenergic antagonists disrupt lordosis behavior in female rats.
Etgen AM
Physiol Behav; 1990 Jul; 48(1):31-6. PubMed ID: 2173005
[TBL] [Abstract][Full Text] [Related]
33. Agonist activation of 5-HT1A receptors in the median raphe nucleus and female rat lordosis behavior.
Uphouse L; Maswood S; Caldarola-Pastuszka M
Brain Res; 1994 Dec; 668(1-2):271-5. PubMed ID: 7704614
[TBL] [Abstract][Full Text] [Related]
34. Effects of ventromedial nucleus lesions on the display of lordosis behavior in the male rat. Interactions with facilitory effects of male urine.
Chateau D; Chabli A; Aron C
Physiol Behav; 1987; 39(3):341-5. PubMed ID: 3575474
[TBL] [Abstract][Full Text] [Related]
35. Effect of progesterone on serotonin turnover in rats primed with estrogen implants into the ventromedial hypothalamus.
Gereau RW; Kedzie KA; Renner KJ
Brain Res Bull; 1993; 32(3):293-300. PubMed ID: 7690679
[TBL] [Abstract][Full Text] [Related]
36. Intracerebral actions of the 5-HT1A agonists, 8-OH-DPAT and buspirone and of the 5-HT1A partial agonist/antagonist, NAN-190, on female sexual behavior.
Uphouse L; Caldarola-Pastuszka M; Montanez S
Neuropharmacology; 1992 Oct; 31(10):969-81. PubMed ID: 1436391
[TBL] [Abstract][Full Text] [Related]
37. Oxytocin effects on lordosis frequency and lordosis duration following infusion into the medial pre-optic area and ventromedial hypothalamus of female rats.
Schulze HG; Gorzalka BB
Neuropeptides; 1991 Feb; 18(2):99-106. PubMed ID: 2017303
[TBL] [Abstract][Full Text] [Related]
38. Localized actions of progesterone in hypothalamus involve oxytocin.
Schumacher M; Coirini H; Frankfurt M; McEwen BS
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6798-801. PubMed ID: 2549547
[TBL] [Abstract][Full Text] [Related]
39. Activation of mu-opioid receptors inhibits lordosis behavior in estrogen and progesterone-primed female rats.
Acosta-Martinez M; Etgen AM
Horm Behav; 2002 Feb; 41(1):88-100. PubMed ID: 11863387
[TBL] [Abstract][Full Text] [Related]
40. Attenuation of the lordosis-inhibiting effects of 8-OH-DPAT by TFMPP and quipazine.
Wolf A; Jackson A; Price T; Trevino A; Caldarola-Pastuszka M; Uphouse L
Brain Res; 1998 Sep; 804(2):206-11. PubMed ID: 9757039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
